Oxaliplatin is a platinum-based chemotherapy drug used to treat various cancers. Its mechanism of action involves several key steps:
-
Activation: Oxaliplatin is a prodrug, meaning it needs to be activated to exert its cytotoxic effects. Once administered, it undergoes a series of chemical reactions that lead to the formation of active platinum species.
-
DNA Binding: The activated platinum species bind to DNA, forming DNA adducts. These adducts can be either intrastrand crosslinks (within a single DNA strand) or interstrand crosslinks (between two DNA strands).
-
DNA Damage: The formation of DNA adducts disrupts the normal structure and function of DNA. This damage prevents DNA replication and transcription, leading to cell cycle arrest and cell death.
-
Cell Death: The DNA damage caused by oxaliplatin triggers a cellular response known as apoptosis, or programmed cell death. This process eliminates cancer cells and helps control tumor growth.
In addition to its direct effects on DNA, oxaliplatin may also have other mechanisms of action, such as:
- Inhibition of DNA repair: Oxaliplatin can interfere with the cellular machinery involved in DNA repair, making it more difficult for cells to repair the damage caused by the drug.
- Induction of oxidative stress: Oxaliplatin can generate reactive oxygen species (ROS), which can damage cellular components and contribute to cell death.
- Modulation of the immune response: Oxaliplatin may have immunomodulatory effects, enhancing the body’s immune response to cancer cells.